Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5759796-oxo-L-homonorleucineMeSH

  structure in first source

• C5762936-phenyl-2,2'-bipyridineMeSH

  structure in first source

• C5782966-phenyl-3-(4-pyridyl)-1,2,4-triazolo-(3,4-b)(1,3,4)thiadiazoleMeSH

  structure in first source

• C5864066-phosphonylmethoxyethoxy-2,4-diaminopyrimidineMeSH

  structure in first source

• C5712696-prenylapigeninMeSH

  from Dorstenia; structure in first source

• C5753886-pyrrolidinyl-2-(2-hydroxyphenyl)-4-quinazolinoneMeSH

  has antineoplastic activity; structure in first source

• C5854626-pyrrolidinyl-2-(3-bromostyryl)quinazolin-4-oneMeSH

  structure in first source

• C5732906-trifluoromethyl-3H-benzoimidazole-4-carboxylic acid (3-(1H-tetrazol-5-yl)-phenyl)amideMeSH

  inhibits CTX-M beta-lactamase; structure in first source

• C5760466-trifluoromethylpyridoxineMeSH

  an NMR pH probe; structure in first source

• C58195562-71-3 monoclonal antibodyMeSH

  a recombinant antibody for rabies prophylaxis in humans

• C56136964Cu(II)-bis(dithiocarbamatebisphosphonate)MeSH

  structure in first source

• C57884264Cu-AmBaSar-RGD2MeSH

  a PET imaging agent for alpha(v)beta(3); structure in first source

• C57309764Cu-CB-TE2A-Y3-TATEMeSH

  a somatostatin receptor subtype 2 agonist; structure in first source

• C57309864Cu-CB-TE2A-sst2-ANTMeSH

  a somatostatin receptor subtype 2 agonist; structure in first source

• C57309664Cu-DOTA-Y3-TATEMeSH

  a somatostatin receptor subtype 2 agonist; structure in first source

• C55984764Cu-DOTA-conatumumabMeSH

  (64)Cu-labeled conatumumab as a PET tracer for imaging Death Receptor-5 in tumors

• C57818064Cu-DOTA-rituximabMeSH

  a CD20 imaging agent

• C57562964Cu-DOTATATEMeSH
• C56040564Cu-cyclam-RAFT-cyclo(arginyl-glycyl-aspartyl-phenylalanyl-lysyl)4MeSH

  a PET probe; structure in first source

• C584120651-blue oxazineMeSH

  structure in first source

• C58837066 KDa protein, Angiostrongylus cantonensisMeSH

  a rat lungworm, the major cause of eosinophilic meningitis

• C58429568Ga-1,4,7-triazacyclononane-1,4-7-triacetic acid-isothiocyanatobenzyl-c(Arg-Gly-Asp-Tyr-Lys)MeSH

  for PET imaging of angiogenesis

• C57256768Ga-DOTA-4-FBn-TN14003MeSH

  structure in first source

• C57114468Ga-DOTA-E-(c(RGDfK))2MeSH

  a PET tracer for alphavbeta3 and alphavbeta5 integrins; structure in first source

• C56174068Ga-DOTA-minigastrinMeSH

  tracer for PET imaging of CCK2/gastrin receptor-positive tumors

• C58787968Ga-DOTA-octreotideMeSH
• C56129968Ga-NODAGA-RGDMeSH

  a PET imaging agent for alphavbeta3 expression; structure in first source

• C58113968Ga-NS3-RGDMeSH

  for alphavbeta3 integrin imaging; structure in first source

• C58113868Ga-TRAP(RGD)3MeSH

  structure in first source

• C58624768Ga-albuminMeSH

  a blood pool PET tracer

• C58608368Ga-labelled DTPA galactosyl human serum albuminMeSH

  used for liver function imaging

• C58114068Ga-oxo-DO3A-RGDMeSH

  for alphavbeta3 integrin imaging; structure in first source

• C5866426A,6A'-dicyclohexylamine-6B,6B'-diselenide-bis-beta-cyclodextrinMeSH

  a glutathione peroxidase mimic

• C5862146H-6-imino-(2,3,4,5-tetrahydropyrimido)(1,2-c)-(1,3)benzothiazineMeSH

  inhibits dimethylarginine dimethylaminohydrolase; structure in first source

• C5621436S-ocoteine N-oxideMeSH

  from Ocotea acutifolia; structure in first source

• C5884096a,12a-dehydroamorphinMeSH

  isolated from Amorpha fruticosa; structure in first source

• C5826856a-epipretazetitineMeSH

  structure in first source

• C5795826alpha,23,24,25-tetraol-16beta-acetoxy-23(R),24(R)-9,19-cyclanosta-3-oneMeSH

  from Astragalus bicuspis; structure in first source

• C5844046alpha,7alpha-diacetoxy-13-hydroxy-8(9),14-labdadienMeSH

  from Vitex trifolia; structure in first source

• C5684376alpha,7beta-dihydroxy-labda-8(17),12(E),14-trieneMeSH

  from Fritillaria ebeiensis; structure in first source

• C5818186b,11b-dihydroxy-6b,11b-dihydro-7H-indeno(1,2-b)naphtho(2,1-d)furan-7-oneMeSH

  a small molecule targeting NF-κB with therapeutic potential in immunopathogenic chronic inflammatory conditions; structure in first source

• C5860026beta,11alpha-dihydroxy-15-oxo-ent-kaur-16-en-19-oic acidMeSH

  from aerial parts of Pteris semipinnata; structure in first source

• C5750516beta,14-epoxyeudesm-4(15)-en-1beta-olMeSH

  isolated from Erigeron philadelphicus.

• C5605086beta,9-dihydroxy-(+)alpha-pineneMeSH

  from Angelica sinensis; structure in first source

• C5704786beta-(hydroxymethyl)penicillanic acid sulfoneMeSH

  inactivates class A and a class C beta-lactamases; structure in first source

• C5703716beta-O-2',3'-dihydrocinnamoyl-12-hydroxy-(13)15-en-16,12-olide-18-cassaneoic acidMeSH

  from Caesalpinia echinata; structure in first source

• C5703726beta-O-cinnamoyl-12-hydroxy-(13)15-en-16,12-olide-18-cassaneoic acidMeSH

  from Caesalpinia echinata; structure in first source

• C5850036beta-cinnamoyloxy-1beta-hydroxy-10alpha-metoxy-3-oxo-germacra-4,5Z-eneMeSH

  antibacterial from Verbesina negrensis; structure in first source

• C5883136beta-hydroxy-5,19-cyclosteroidMeSH

  structure in first source

• C5798726q24-Related Transient Neonatal Diabetes MellitusMeSH